Published in Invest Ophthalmol Vis Sci on May 01, 2006
In vivo human choroidal thickness measurements: evidence for diurnal fluctuations. Invest Ophthalmol Vis Sci (2008) 1.83
Pharmacology of myopia and potential role for intrinsic retinal circadian rhythms. Exp Eye Res (2013) 0.95
Diurnal variations in blood flow at optic nerve head and choroid in healthy eyes: diurnal variations in blood flow. Medicine (Baltimore) (2015) 0.91
The short-term influence of exercise on axial length and intraocular pressure. Eye (Lond) (2011) 0.91
Non-contact measurement of linear external dimensions of the mouse eye. J Neurosci Methods (2010) 0.88
Ocular diurnal rhythms and eye growth regulation: where we are 50 years after Lauber. Exp Eye Res (2013) 0.86
Increased 24-hour variation of human intraocular pressure with short axial length. Invest Ophthalmol Vis Sci (2009) 0.86
Changes in axial length and choroidal thickness after intraocular pressure reduction resulting from trabeculectomy. Clin Ophthalmol (2013) 0.81
Brief light exposure at night disrupts the circadian rhythms in eye growth and choroidal thickness in chicks. Exp Eye Res (2016) 0.81
Effects of diurnal, lighting, and angle-of-incidence variation on anterior segment optical coherence tomography (AS-OCT) angle metrics. BMC Ophthalmol (2017) 0.75
Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med (2011) 19.42
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology (2012) 11.91
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet (2009) 6.71
A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol (2003) 5.27
Comparison of preschool vision screening tests as administered by licensed eye care professionals in the Vision In Preschoolers Study. Ophthalmology (2004) 4.98
A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology (2003) 4.88
A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology (2004) 3.48
Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol (2005) 3.42
15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol (2005) 3.13
Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol (2003) 2.37
Darkness and near work: myopia and its progression in third-year law students. Ophthalmology (2002) 2.33
Agreement among pediatric ophthalmologists in diagnosing plus and pre-plus disease in retinopathy of prematurity. J AAPOS (2008) 2.15
Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. Arch Ophthalmol (2002) 2.13
Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology (2008) 2.10
Nearwork in early-onset myopia. Invest Ophthalmol Vis Sci (2002) 2.01
POSTNATAL SERUM INSULIN-LIKE GROWTH FACTOR I AND RETINOPATHY OF PREMATURITY. Retina (2016) 1.93
In vivo human choroidal thickness measurements: evidence for diurnal fluctuations. Invest Ophthalmol Vis Sci (2008) 1.83
Retinal nerve fiber layer thickness in children with optic pathway gliomas. Am J Ophthalmol (2011) 1.80
Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology (2009) 1.74
Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years. Ophthalmology (2007) 1.73
Systematic review of digital imaging screening strategies for retinopathy of prematurity. Pediatrics (2008) 1.64
Treatment of bilateral refractive amblyopia in children three to less than 10 years of age. Am J Ophthalmol (2007) 1.64
Computerized analysis of retinal vessel width and tortuosity in premature infants. Invest Ophthalmol Vis Sci (2008) 1.58
Stereoacuity of preschool children with and without vision disorders. Optom Vis Sci (2014) 1.58
Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age. J AAPOS (2008) 1.55
Progression to severe retinopathy predicted by retinal vessel diameter between 31 and 34 weeks of postconception age. Arch Ophthalmol (2007) 1.52
A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. Ophthalmology (2010) 1.47
Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology (2009) 1.46
Knockout of A3 adenosine receptors reduces mouse intraocular pressure. Invest Ophthalmol Vis Sci (2002) 1.37
Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age. J AAPOS (2008) 1.36
Component dependent risk factors for ocular parameters in Singapore Chinese children. Ophthalmology (2002) 1.36
IQ and the association with myopia in children. Invest Ophthalmol Vis Sci (2004) 1.35
Visual acuity through Bangerter filters in nonamblyopic eyes. J AAPOS (2011) 1.34
A cohort study of incident myopia in Singaporean children. Invest Ophthalmol Vis Sci (2006) 1.33
Height and its relationship to refraction and biometry parameters in Singapore Chinese children. Invest Ophthalmol Vis Sci (2002) 1.29
Standard image of plus disease in retinopathy of prematurity. Arch Ophthalmol (2006) 1.27
Are we there yet? Bevacizumab therapy for retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed (2011) 1.23
A clinical prediction model to stratify retinopathy of prematurity risk using postnatal weight gain. Pediatrics (2011) 1.23
Effect of age on response to amblyopia treatment in children. Arch Ophthalmol (2011) 1.22
Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity. Ophthalmology (2005) 1.21
Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity. Ophthalmology (2010) 1.19
The cross-species A3 adenosine-receptor antagonist MRS 1292 inhibits adenosine-triggered human nonpigmented ciliary epithelial cell fluid release and reduces mouse intraocular pressure. Curr Eye Res (2005) 1.17
Diurnal axial length fluctuations in human eyes. Invest Ophthalmol Vis Sci (2004) 1.16
The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Arch Ophthalmol (2012) 1.15
Telemedicine screening for retinopathy of prematurity in developing countries using digital retinal images: a feasibility project. J AAPOS (2008) 1.15
Further validation of the Amblyopia Treatment Index parental questionnaire. J AAPOS (2008) 1.14
Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology (2009) 1.13
Clinical characteristics of children with severe visual impairment but favorable retinal structural outcomes from the Early Treatment for Retinopathy of Prematurity (ETROP) study. J AAPOS (2013) 1.10
Astigmatism in the Early Treatment for Retinopathy Of Prematurity Study: findings to 3 years of age. Ophthalmology (2008) 1.09
Is drusen area really so important? Invest Ophthalmol Vis Sci (2012) 1.06
Predictive value of pre-plus disease in retinopathy of prematurity. Arch Ophthalmol (2011) 1.05
Office probing for treatment of nasolacrimal duct obstruction in infants. J AAPOS (2014) 1.04
Associations between childhood refraction and parental smoking. Invest Ophthalmol Vis Sci (2006) 1.02
Highly precise eye length measurements in children aged 3 through 12 years. Arch Ophthalmol (2003) 1.02
Iron levels in human retina: sex difference and increase with age. Neuroreport (2006) 1.01
Investigating mechanisms of myopia in mice. Exp Eye Res (2013) 1.00
Form-deprivation myopia in chick induces limited changes in retinal gene expression. Invest Ophthalmol Vis Sci (2007) 1.00
Astigmatism progression in the early treatment for retinopathy of prematurity study to 6 years of age. Ophthalmology (2011) 0.99
Inhibitors of NHE-1 Na+/H+ exchange reduce mouse intraocular pressure. Invest Ophthalmol Vis Sci (2002) 0.99
Assessment of axial length measurements in mouse eyes. Optom Vis Sci (2012) 0.99
Degradation of extracellular ATP by the retinal pigment epithelium. Am J Physiol Cell Physiol (2005) 0.98
Severe visual impairment in children with mild or moderate retinal residua following regressed threshold retinopathy of prematurity. J AAPOS (2007) 0.98
Evaluation of a behavioral method for objective vision testing and identification of achromatopsia in dogs. Am J Vet Res (2010) 0.97
The impact of pediatric vision disorders in adulthood. Pediatrics (2011) 0.97
Visual acuity at 10 years in Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) study eyes: effect of retinal residua of retinopathy of prematurity. Arch Ophthalmol (2006) 0.97
Effect of Viagra on the foveolar choroidal circulation of AMD patients. Exp Eye Res (2005) 0.97
Association between breastfeeding and likelihood of myopia in children. JAMA (2005) 0.95
Noninvasive intraocular pressure measurements in mice by pneumotonometry. Invest Ophthalmol Vis Sci (2005) 0.95
Birth order and myopia. Ophthalmic Epidemiol (2013) 0.94
The rate of retinal vessel dilation in severe retinopathy of prematurity requiring treatment. Am J Ophthalmol (2009) 0.93
VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT). JAMA Ophthalmol (2014) 0.92
Vision screening for children 36 to <72 months: recommended practices. Optom Vis Sci (2015) 0.91
Educational and social competencies at 8 years in children with threshold retinopathy of prematurity in the CRYO-ROP multicenter study. Pediatrics (2004) 0.90
Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species. Exp Eye Res (2009) 0.88
Nicotinic acetylcholine receptor subunits in rhesus monkey retina. Invest Ophthalmol Vis Sci (2008) 0.87
Retinal degeneration increases susceptibility to myopia in mice. Mol Vis (2013) 0.87
Ocular dominance, laterality, and refraction in Singaporean children. Invest Ophthalmol Vis Sci (2007) 0.85
Age-dependent and gender-specific changes in mouse tissue iron by strain. Exp Gerontol (2009) 0.85
Semiautomated digital image analysis of posterior pole vessels in retinopathy of prematurity. J AAPOS (2009) 0.84
Survey of childhood blindness and visual impairment in Botswana. Br J Ophthalmol (2011) 0.84
Stimulation of an alpha1-adrenergic receptor downregulates ecto-5' nucleotidase activity on the apical membrane of RPE cells. Purinergic Signal (2006) 0.84
Noninvasive assessment of aqueous humor turnover in the mouse eye. Invest Ophthalmol Vis Sci (2003) 0.83
Retinal vessel changes after laser treatment for retinopathy of prematurity. J AAPOS (2012) 0.83
Barrier qualities of the mouse eye to topically applied drugs. Exp Eye Res (2007) 0.83
Effectiveness of prisms in the management of diplopia in patients due to diverse etiologies. J Pediatr Ophthalmol Strabismus (2012) 0.83
Emmetropisation under continuous but non-constant light in chicks. Exp Eye Res (2004) 0.82
3D chemical mapping: application of scanning transmission (soft) X-ray microscopy (STXM) in combination with angle-scan tomography in bio-, geo-, and environmental sciences. Methods Mol Biol (2014) 0.82